Why Amgen's $1.9 Billion Takeover Might Only Whet Its Appetite In 2021

Why Amgen's $1.9 Billion Takeover Might Only Whet Its Appetite In 2021

Amgen said Thursday it will spend $1.9 billion to buy Five Prime Therapeutics, a small biotech company with a promising stomach cancer drug. The news sent FPRX stock rocketing.